-

AHF Files Federal Antitrust Lawsuit Against the PBM Prime Therapeutics

Lawsuit asserts Prime Therapeutics unlawfully fixes the prices of its reimbursements to AHF and other independent pharmacies, to align with reimbursements of a direct Prime competitor

LOS ANGELES--(BUSINESS WIRE)--Today, AIDS Healthcare Foundation (AHF), the leading provider of health care to people living with HIV/AIDS around the world, filed a lawsuit in federal court in Los Angeles to stop Prime Therapeutics LLC from fixing prices of reimbursements to AHF pharmacies, along with all other independent pharmacies doing business with Prime, for providing prescription drugs to patients in need. The action was filed in U.S. District Court, Central District of California (Case No. 2:21-cv-04979).

Prime is a pharmacy benefit manager (PBM), a “middle-man” in the distribution system for prescription drugs in the United States. In its capacity as a PBM, Prime acts as a gatekeeper between pharmacies and health insurers.1 The PBM boasts of administering the pharmacy-benefits components of health-insurance plans for about 33 million people in the United States. Some of those people are patients of AHF pharmacies, and, in 2020, Prime processed almost 100,000 drug prescriptions for AHF patients.

In late 2019, Prime announced “a new three-year collaboration” with another PBM, Express Scripts, Inc. The word “collaboration” suggests something complicated. In fact, it appears Prime is simply aligning its reimbursement rates with those of the other PBM, and doing so on an ongoing basis. AHF’s pleading asserts that Prime is thereby violating the most settled principle of antitrust law, the prohibition against fixing prices with a direct competitor.

Almost immediately after the “collaboration” went into effect in the spring of 2020, AHF noticed that it was being reimbursed less than before for providing the same pharmacy services to patients whose PBM is Prime. Indeed, those reimbursement rates now line up exactly with those of the other competitor PBM.

“The reimbursement money Prime has been unlawfully taking from AHF is money that can no longer fund the specialized care and lifesaving services that AIDS Healthcare Foundation offers to people living with HIV/AIDS -- regardless of a patient’s ability to pay,” said Jonathan M. Eisenberg, Deputy General Counsel for AHF. “There is thus a real human cost here.”

With its lawsuit, AIDS Healthcare Foundation is now standing up to Prime, a powerful PBM that essentially controls access to many insured patients that use AHF pharmacies and healthcare centers, as well as on behalf of other independent pharmacies.

“AIDS Healthcare Foundation has real reason to fear that we may face retaliation from Prime for exposing it as a price-fixer,” added Eisenberg. “However, we take that risk on behalf of the patients and clients we serve and many other independent pharmacies to try to stop Prime’s flagrantly unlawful scheme.”

About the lawsuit, AIDS Healthcare Foundation President Michael Weinstein added, “PBMs are very powerful, and they always are tempted to squeeze pharmacies financially. Somehow Prime found out that it was giving larger reimbursements to pharmacies than another PBM. Apparently, Prime just could not leave a single dime on the table and resorted to fixing prices. AIDS Healthcare Foundation and its patients – and other independent pharmacies and their patients – are literally paying the price for that crime. But we are fighting back, and we are going to win.”

Here again is a link to a copy of the complaint: [Case No. 2:21-cv-04979].

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.5 million clients in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

1 Note: Prime is, in fact, owned by a group of Blue Cross and/or Blue Shield health insurers.

Contacts

Ged Kenslea, AHF Communications Dir., gedk@aidshealth.org (323) 791-5526 cell

AIDS Healthcare Foundation


Release Summary
AHF Files Federal Antitrust Lawsuit Against the PBM Prime Therapeutics
Release Versions

Contacts

Ged Kenslea, AHF Communications Dir., gedk@aidshealth.org (323) 791-5526 cell

More News From AIDS Healthcare Foundation

Latin America’s PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHF

MEXICO CITY--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the world’s largest HIV care provider, welcomes a new agreement between Gilead Sciences and the Pan American Health Organization (PAHO) that could expand access to lenacapavir for HIV prevention in 14 countries across Latin America. The agreement represents a positive step toward expanding access in the region and a victory for civil society. AHF was among the first organizations to mobilize around concerns that the initial Gilead-...

AHF to Commemorate 40 Years of Global Impact During Annual World AIDS Day Concert Celebration

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the world’s largest, non-profit public health organization providing direct HIV/AIDS services to over 3.3 million clients across the globe, will celebrate 40 years of impact during its annual World AIDS Day concert commemoration. The event, which is free and open to the public, is scheduled for the evening of Monday, November 30, 2026, at the Kia Forum in Inglewood, California. RSVP to AHFWAD.org for tickets. Commemorated annually...

Sexual Health Is Health: Testing, Treatment and Prevention for All, says AHF

LOS ANGELES--(BUSINESS WIRE)--As sexually transmitted infections continue to rise worldwide, AIDS Healthcare Foundation (AHF) marks World Sexual Health Day by calling on governments and health systems to expand access to prevention, testing, and treatment services for HIV and other STIs. Despite proven tools to prevent, diagnose, and treat HIV and other STIs, gaps in access continue to put millions of people at risk globally. With an estimated 1.2 million new HIV infections each year globally,...
Back to Newsroom